Company name Apple Inc.
Stock ticker AAPL
Live stock price [stckqut]AAPL[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Good
Target stock price (TWCA growth scenario) $602.59
Target stock price (averages with growth) $893.69
Target stock price (averages with no growth) $677.7
Target stock price (manual assumptions) $585.42

The following company description is from Google Finance: http://www.google.com/finance?q=aapl

Apple Inc. (Apple) designs, manufactures and markets a range of personal computers, mobile communication and media devices, and portable digital music players, and sells a range of related software, services, peripherals, networking solutions, and third-party digital content and applications. It’s products and services include Macintosh (Mac) computers, iPhone, iPad, iPod, Apple TV, Xserve, a portfolio of consumer and professional software applications, the Mac OS X and iOS operating systems, third-party digital content and applications through the iTunes Store, and a range of accessory, service and support offerings. The Company sells its products globally through its retail stores, online stores, and direct sales force and third-party cellular network carriers, wholesalers, retailers, and value-added resellers. As of September 25, 2010, the Company had opened a total of 317 retail stores, including 233 stores in the United States and 84 stores internationally.

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.

Company name VirnetX Holding Corporation
Stock ticker VHC
Live stock price [stckqut]VHC[/stckqut]
Confident Investor Rating Poor

The following company description is from Google Finance: http://www.google.com/finance?q=vhc

VirnetX Holding Corporation (VirnetX) is a development-stage company. The Company is engaged in developing and commercializing software and technology solutions for securing real-time communications over the Internet. The Company is focused commercializing a patent portfolio for securing real-time communications over the Internet. These patents were acquired by its principal operating subsidiary, VirnetX, from Science Applications International Corporation (SAIC). The Company’s GABRIEL Connection Technology combines industry standard encryption protocols with its patented techniques for automated domain name system (DNS), lookup mechanisms, enabling users to create a secure communication link using secure domain names. Its software and technology solutions provide the security platform required by next-generation Internet-based applications, such as instant messaging (IM), voice over Internet protocol (VoIP), mobile services, streaming video, file transfer and remote desktop.

Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock. It is not possible to confidently invest in a company that is not currently profitable.

Company name USANA Health Sciences, Inc.
Stock ticker USNA
Live stock price [stckqut]USNA[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $40.53
Target stock price (averages with growth) $64.89
Target stock price (averages with no growth) $55.14
Target stock price (manual assumptions) $35.46

The following company description is from Google Finance: http://www.google.com/finance?q=usna

USANA Health Sciences, Inc. (USANA) develops and manufactures high-quality, science-based nutritional and personal care products, with a commitment to continuous product innovation and sound scientific research. Its customer base consists of two types of customers: Associates and Preferred Customers. Associates are independent distributors of its products, who also purchase its products for personal use. Preferred Customers purchase its products for personal use and are not permitted to resell or to distribute the products. As of January 2, 2010, it had 199,000 active Associates and 67,000 active Preferred Customers worldwide. USANA sells products from two primary product lines: USANA Nutritionals, which includes high-quality supplements and functional foods, and Sense-beautiful science (Sense), a line of skin and personal care products.

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

Company name U.S. Physical Therapy, Inc.
Stock ticker USPH
Live stock price [stckqut]USPH[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Poor
Sales growth Fair
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $16.72
Target stock price (averages with growth) $24.12
Target stock price (averages with no growth) $22.88
Target stock price (manual assumptions) $19.6

The following company description is from Google Finance: http://www.google.com/finance?q=usph

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical and occupational therapy clinics that provide pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The Company also operates two clinics, which specialize in the outpatient, non-surgical treatment of osteo arthritis degeneration joint disease and other musculoskeletal conditions. It primarily operates through subsidiary clinic partnerships in which it generally owns a 1% general partnership interest and a 64% limited partnership interest and the managing therapist(s) of the clinics owns the remaining limited partnership interest in the majority of the clinics (referred to as Clinic Partnerships). In March 2010, the Company acquired a 70% interest in a five clinic outpatient physical therapy group. In July 2011, the Company acquired 20 clinic physical therapy group.

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

Company name Gildan Activewear Inc. (USA)
Stock ticker GIL
Live stock price [stckqut]GIL[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $41.75
Target stock price (averages with growth) $87.74
Target stock price (averages with no growth) $93.42
Target stock price (manual assumptions) $35.93

The following company description is from Google Finance: http://www.google.com/finance?q=gil

Gildan Activewear Inc. (Gildan) is a Canada-based company. The Company is a marketer and vertically-integrated global manufacturer of basic, non-fashion apparel products for customers. It sells active wear products to screen print markets in North America, Europe and other international markets. Gildan is a supplier of active wear for the screen print channel in the United States and Canada, and also a supplier for this market in Europe and Mexico. It sells socks and underwear, in addition to its active wear products, to mass market and regional retailers in North America. In the United States mass market retail channel, Gildan is a supplier of socks. The Company operates in one business segment non-fashion apparel. On March 31, 2010, the Company completed the acquisition of Shahriyar Fabric Industries Limited (Shahriyar).In April 2011, the Company acquired Gold Toe Moretz Holdings Corp.

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.